ARKB vs. ARKG
ARKB (ARK 21Shares Bitcoin ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - ARKB is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant, while ARKG is a Health & Biotech Equities fund actively managed by ARK. ARKB is passively managed, while ARKG is actively managed. Over the past year, ARKB returned -43.47% vs 59.88% for ARKG. At a 0.37 correlation, their price movements are largely independent. ARKB charges 0.21%/yr vs 0.75%/yr for ARKG.
Performance
ARKB vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKB achieves a -31.61% return, which is significantly lower than ARKG's 33.17% return.
ARKB
- 1D
- -3.97%
- 1M
- -20.99%
- YTD
- -31.61%
- 6M
- -31.45%
- 1Y
- -43.47%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG
- 1D
- 7.14%
- 1M
- 25.79%
- YTD
- 33.17%
- 6M
- 27.83%
- 1Y
- 59.88%
- 3Y*
- 5.57%
- 5Y*
- -15.49%
- 10Y*
- 9.42%
ARKB vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | -31.61% | -6.59% | 86.54% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 33.17% | 23.04% | -26.95% |
Correlation
The correlation between ARKB and ARKG is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Jan 11, 2024 | 0.37 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKB vs. ARKG — Risk / Return Rank
ARKB
ARKG
ARKB vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK 21Shares Bitcoin ETF (ARKB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKB | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.38 | ||
| Sortino ratioReturn per unit of downside risk | -3.54 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.24 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.83 | 2.19 | -3.02 |
| Martin ratioReturn relative to average drawdown | -1.42 | 5.21 | -6.63 |
Loading charts...
Drawdowns
ARKB vs. ARKG - Drawdown Comparison
The maximum ARKB drawdown since its inception was -52.37%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for ARKB and ARKG.
Loading charts...
Drawdown Indicators
| ARKB | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.37% | -83.59% | +31.22% |
Max Drawdown (1Y)Largest decline over 1 year | -52.37% | -27.51% | -24.86% |
Max Drawdown (3Y)Largest decline over 3 years | — | -51.96% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -80.18% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -52.37% | -65.48% | +13.11% |
Average DrawdownAverage peak-to-trough decline | -16.93% | -36.03% | +19.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.72% | 11.53% | +19.19% |
Volatility
ARKB vs. ARKG - Volatility Comparison
The current volatility for ARK 21Shares Bitcoin ETF (ARKB) is 13.35%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 16.36%. This indicates that ARKB experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKB | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.35% | 16.36% | -3.01% |
Volatility (6M)Calculated over the trailing 6-month period | 34.46% | 31.57% | +2.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.28% | 43.09% | +1.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.07% | 46.04% | +4.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 50.07% | 41.34% | +8.73% |
ARKB vs. ARKG - Expense Ratio Comparison
ARKB has a 0.21% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
ARKB vs. ARKG - Dividend Comparison
Neither ARKB nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKB and ARKG have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (16.36%) compared to ARKB (13.35%). In terms of maximum drawdown, ARKB dropped -52.37% vs ARKG's -83.59%.
On 1-year performance, ARKG leads with 59.88% vs -43.47% for ARKB. On fees, ARKB is cheaper at 0.21% per year. On volatility, ARKB has been the lower-risk option at 13.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 59.88% return vs -43.47%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKB is cheaper with a 0.21% expense ratio, compared with 0.75% for ARKG.
ARKB and ARKG have nearly identical dividend yields, around 0.00%.
ARKB is categorized as Cryptocurrency, while ARKG is Health & Biotech Equities. Their fees differ too: 0.21% for ARKB and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.40 vs -0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKB and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer